brl 46470 has been researched along with 1-(3-chlorophenyl)piperazine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cowen, PJ; Silverstone, PH | 1 |
1 trial(s) available for brl 46470 and 1-(3-chlorophenyl)piperazine
Article | Year |
---|---|
The 5-HT3 antagonist, BRL 46470 does not attenuate m-chlorophenylpiperazine (mCPP)-induced changes in human volunteers.
Topics: Administration, Oral; Adolescent; Adult; Anti-Anxiety Agents; Anxiety; Brain; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cross-Over Studies; Double-Blind Method; Humans; Hydrocortisone; Indoles; Infusions, Intravenous; Male; Middle Aged; Panic; Piperazines; Premedication; Prolactin; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1994 |